Publications by authors named "David C Titton"

Claim this Profile
T
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis.
Markus Bredemeier, Ângela L Duarte, Marcelo M Pinheiro, Bárbara S Kahlow, José C Macieira, David C Titton

Rheumatology (Oxford)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
Markus Bredemeier, Roberto Ranza, Adriana M Kakehasi, Aline Ranzolin, Inês G da Silveira, David C Titton

J Rheumatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
Markus Bredemeier, Roberto Ranza, Adriana M Kakehasi, Aline Ranzolin, Inês G da Silveira, David C Titton

J Rheumatol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Infectious Adverse Events in Patients With Rheumatoid Arthritis and Spondyloarthritis on Biologic Drugs-Data From the Brazilian Registry for Biologics Monitoring.
Mariana Cecconi, Roberto Ranza, David C Titton, Júlio C B Moraes, Manoel Bertolo

J Clin Rheumatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases (Registro Brasileiro de Monitoração de Terapias Biológicas - BiobadaBrasil).
Claudia Leiko Yonekura, Rene Donizeti Ribeiro Oliveira, David C Titton, Roberto Ranza, Aline Ranzolin

Rev Bras Reumatol Engl Ed· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR.
Roberto Ranza, Maria Celina de la Vega, Ieda Maria Magalhães Laurindo, Marìa Gimena Gómez, David Cezar Titton

Clin Rheumatol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL.
Bárbara P Fafá, Paulo Louzada-Junior, David C Titton, Eliana Zandonade, Roberto Ranza

Clin Rheumatol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BiobadaBrasil: Brazilian biologic registry.
David C Titton

Rev Bras Reumatol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brazilian biologic registry: BiobadaBrasil implementation process and preliminary results.
David C Titton, Ines Guimarães Silveira, Paulo Louzada-Junior, Andre L Hayata, Hellen Mary S Carvalho

Rev Bras Reumatol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis